Literature DB >> 21033124

[Relationship between serum IL-8 hsCRP, TNF-α and coronary lesions in CHD patients].

Jin-guang Luo1.   

Abstract

AIM: To study the relationship between serum inflammation factors interleukin-8 (IL-8), high-sensitivity C-reaction protein, tumor necrosis factor-α and coronary lesions in coronary heart disease (CHD) patients,
METHODS: One hundred and six CHD patients were enrolled, 100 healthy subjects served as control group. The levels of serum IL-8, hsCRP (by) and TNF-α were determined. Coronary lesions were calculated by Gensini method.
RESULTS: The levels of Serum IL-8, hsCRP and TNF-α in CHD group were significantly higher than those in control group were significantly higher than those in control group (P < 0.05), and serum IL-8, hsCRP and TNF-α in CHD group increased gradually with the increase of Gensini score (P < 0.05). Pearson correlation analysis showed that Gensini score was positively correlated to IL-8 (P < 0.05), hsCRP (P < 0.05) and TNF-α (P < 0.05) in CHD group.
CONCLUSION: Severity of coronary lesions in CHD patients may be related to the levels of serum IL-8, hsCRP and TNF-α.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21033124

Source DB:  PubMed          Journal:  Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi        ISSN: 1007-8738


  3 in total

1.  The Correlation between High-Sensitivity C-Reactive Protein (hsCRP) Serum Levels and Severity of Coronary Atherosclerosis.

Authors:  Mohammad Assadpour Piranfar
Journal:  Int Cardiovasc Res J       Date:  2014-01-01

2.  Relationship between high-sensitivity C-reactive protein serum levels and the severity of coronary artery stenosis in patients with coronary artery disease.

Authors:  Seyed Masoud Seyedian; Farzaneh Ahmadi; Razieh Dabagh; Hannaneh Davoodzadeh
Journal:  ARYA Atheroscler       Date:  2016-09

3.  Trend of Galectin-3 Levels in Patients with Non-ST-Elevation and ST-Elevation Myocardial Infarction.

Authors:  Branka Mitić; Andriana Jovanović; Valentina N Nikolić; Dragana Stokanović; Olivera M Andrejić; Rada M Vučić; Milan Pavlović; Aleksandra Ignjatović; Stefan Momčilović
Journal:  Medicina (Kaunas)       Date:  2022-02-14       Impact factor: 2.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.